Current Strategies on the Enantioselective Synthesis of Modified Nucleosides

Samir Kumar Mondal; Birkishore Mahto; Shantanu Pal; Girish Chandra

doi:10.1055/a-2212-8502

Synlett, Inhaltsverzeichnis

Synlett 2024; 35(06): 616-634
DOI: 10.1055/a-2212-8502

account

Special Issue to Celebrate the Centenary Year of Prof. Har Gobind Khorana

Current Strategies on the Enantioselective Synthesis of Modified Nucleosides

Samir Kumar Mondal

^aSchool of Basic Sciences, Indian Institute of Technology, Bhubaneswar, Argul, Odisha, 752050, India

,

Birkishore Mahto

^bDepartment of Chemistry, School of Physical and Chemical Sciences, Central University of South Bihar, SH-7Panchanpur Road, Gaya, Bihar, 824236, India

,

Shantanu Pal∗

^aSchool of Basic Sciences, Indian Institute of Technology, Bhubaneswar, Argul, Odisha, 752050, India

,

Girish Chandra∗

^bDepartment of Chemistry, School of Physical and Chemical Sciences, Central University of South Bihar, SH-7Panchanpur Road, Gaya, Bihar, 824236, India

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

The isolation of two carbocyclic nucleosides, viz., neplanocin A and aristeromycin, from natural sources, triggered a revolution in the scientific community, leading to the development of more versatile and therapeutically useful compounds. For this purpose, many new methods for the synthesis of the carbocyclic framework of nucleosides have been developed. These efforts resulted in the successful development of many marketable drugs. The inherent benefits associated with carbocyclic nucleosides, such as higher lipophilicity and metabolic stability, resistance against glycosidic hydrolysis and the ability to modify aromatic bases by cellular phosphorylases, make them popular for the development of drugs against cancer and different viruses. Classically, carbocyclic nucleosides of various ring sizes and configurations have been synthesized starting from chiral pool substrates, such as ribose, glucose, etc., but recently, many other new asymmetric versions have been developed. Herein, we present recent developments on the catalytic enantioselective synthesis of nucleoside analogues, including carbocyclic and other varieties. This account provides new insights into the future development of modified nucleosides.

1 Introduction

2 Cyclic Nucleosides

3 Acyclic Nucleosides

4 Conclusion

Keywords

nucleosides - asymmetric synthesis - enantioselectivity - diastereoselectivity - carbocyclic nucleosides - asymmetric catalysis

Volltext

Referenzen

References
1 De Clercq EJ. Clin. Virol. 2004; 30: 115
2 Guinan M, Benckendorff C, Smith M, Miller GJ. Molecules 2020; 25: 2050
3 Man S, Lu Y, Yin L, Cheng X, Ma L. Drug Discovery Today 2021; 26: 1490
4 Chandra G, Patel S, Panchal M, Singh DV. Mini-Rev. Med. Chem. 2021; 21: 833
5 Zenchenko AA, Drenichev MS, Mikhailov SN. Curr. Med. Chem. 2021; 28: 5284
6 Chandra G, Singh DV, Mahato GK, Patel S. Chem. Pap. 2023; 77: 4085
7 Chandra G, Majik MS, Lee JY, Jeong LS. Org. Lett. 2012; 14: 2134

8a Alexander V, Choi WJ, Chun J, Kim HO, Jeon JH, Tosh DK, Lee HW, Chandra G, Choi J, Jeong LS. Org. Lett. 2010; 12: 2242
8b Yu J, Kim JW, Chandra G, Saito-Tarashima N, Nogi Y, Ota M, Minakawa N, Jeong LS. Bioorg. Med. Chem. Lett. 2023; 83: 129172

9 Choi WJ, Chung H.-J, Chandra G, Alexander V, Zhao LX, Lee HW, Nayak A, Majik MS, Kim HO, Kim J.-H, Lee YB, Ahn CH, Lee SK, Jeong LS. J. Med. Chem. 2012; 55: 4521
10 Chandra G, Moon YW, Lee Y, Jang JY, Song J, Nayak A, Oh K, Mulamoottil VA, Sahu PK, Kim G, Chang T.-S, Noh M, Lee SK, Choi S, Jeong LS. J. Med. Chem. 2015; 58: 5108
11 Jeong LS, Pal S, Choe SA, Choi WJ, Jacobson KA, Gao Z.-G, Klutz AM, Hou X, Kim HO, Lee HW, Lee SK, Tosh DK, Moon HR. J. Med. Chem. 2008; 51: 6609
12 Mulamoottil VA, Majik MS, Chandra G, Jeong LS. Recent Advances in Synthesis and Biological Activity of 4-Thionucleosides . In Chemical Synthesis of Nucleoside Analogues . Merino P. John Wiley & Sons; Hoboken: 2013: 655
13 Sivakrishna B, Shukla M, Santra MK, Pal S. Carbohydr. Res. 2020; 497: 108113
14 Sivakrishna B, Islam S, Santra MK, Pal S. Drug Dev. Res. 2020; 81: 274
15 Sivakrishna B, Islam S, Panda A, Saranya M, Santra MK, Pal S. Anticancer Agents Med. Chem. 2019; 18: 1425
16 Choi MJ, Chandra G, Lee HW, Hou X, Choi WJ, Phan K, Jacobson KA, Jeong LS. Org. Biomol. Chem. 2011; 9: 6955
17 Choi WJ, Ko YJ, Chandra G, Lee HW, Kim HO, Koh HJ, Moon HR, Jung YH, Jeong LS. Tetrahedron 2012; 68: 1253
18 Li J.-P, Tuo H.-R, Xie M.-S, Kang B, Qu G.-R, Guo H.-M. Asian J. Org. Chem. 2018; 7: 128
19 Kusaka T, Yamamoto H, Shibata M, Muroi M, Kishi T, Mizuno K. J. Antibiot. (Tokyo) 1968; 21: 255
20 Yaginuma S, Muto N, Tsujino M, Sudate Y, Hayashi M, Otani M. J. Antibiot. (Tokyo) 1981; 34: 359
21 Das S, Panda A, Pal S. Carbohydr. Res. 2015; 416: 24
22 Panda A, Satpati S, Dixit A, Pal S. RSC Adv. 2016; 6: 11233
23 Wang T, Lee HJ, Tosh DK, Kim HO, Pal S, Choi S, Lee Y, Moon HR, Zhao LX, Lee KM, Jeong LS. Bioorg. Med. Chem. Lett. 2007; 17: 4456

24a Manna MS, Mukherjee S. Org. Biomol. Chem. 2015; 13: 18
24b Pfeiffer M, Nidetzky B. Curr. Opin. Biotechnol. 2023; 79: 102873

25a Vaidya T, Eisenberg R, Frontier AJ. ChemCatChem 2011; 3: 1531
25b Rajapaksha DG, Mondal S, Wang JW, Meanwell MW. Med. Chem. Res. 2023; 32: 1315

26a Boutureira O, Matheu MI, Díaz Y, Castillón S. Chem. Soc. Rev. 2013; 42: 5056
26b Shet H, Sahu R, Sanghvi YS, Kapdi AR. Chem. Rec. 2022; 22: e202200066
26c Giesen KJ. D. V, Thompson MJ, Meng Q, Lovelock SL. JACS Au 2023; 3: 13
26d Maria C, Rauter AP. Carbohydr. Res. 2023; 532: 108889

27a Nagai K, Kiguchi S, Koyama H, Hume EW, Tsujimoto S. EP2228373B1, 2008
27b Davison EK, Petrone DA, Meanwell M, Nodwell MB, Silverman SM, Campeau L.-C, Britton R. Nat. Protoc. 2022; 17: 2008

28a Xie MS, Wang Y, Li JP, Du C, Zhang YY, Hao EJ, Zhang YM, Qu GR, Guo HM. Chem. Commun. 2015; 51: 12451
28b Guo H.-M, Yuan T.-F, Niu H.-Y, Liu J.-Y, Mao R.-Z, Li D.-Y, Qu G.-R. Chem. Eur. J. 2011; 17: 4095

29 Racine S, Denanteuil F, Serrano E, Waser J. Angew. Chem. Int. Ed. 2014; 53: 8484
30 Huang KX, Xie MS, Zhang QY, Niu HY, Qu GR, Guo HM. Org. Lett. 2018; 20: 5398
31 Huang K.-X, Xie M.-S, Zhang Q.-Y, Qu G.-R, Guo H.-M. Org. Lett. 2018; 20: 389
32 Huang KX, Xie MS, Wang DC, Sang JW, Qu GR, Guo HM. Chem. Commun. 2019; 55: 13550
33 Gao Y.-W, Niu H.-Y, Zhang Q.-Y, Xie M.-S, Qu G.-R, Guo H.-M. Adv. Synth. Catal. 2018; 360: 2813
34 Kang S, Jang SH, Lee J, Kim DG, Kim M, Jeong W, Rhee YH. Org. Lett. 2017; 19: 4684
35 Yang Q, Xie M, Xia C, Sun H, Zhang D, Huang K, Guo Z, Qu G, Guo H. Chem. Commun. 2014; 50: 14809
36 Patel NR, Nawrat CC, McLaughlin M, Xu Y, Hu MA, Yang H, Fryszkowska A, Li H, Whittaker AM, Andreani T, Brunskill A, Tschaen DM, Maloney KM. Org. Lett. 2020; 22: 4659
37 Zhang Y.-M, Zhang Q.-Y, Wang D.-C, Xie M.-S, Qu G.-R, Guo H.-M. Org. Lett. 2019; 21: 2998
38 You C, Wei B, Li X, Yang Y, Liu Y, Lv H, Zhang X. Angew. Chem. 2016; 128: 6621
39 Jurado S, Dom B, Illa O, Balzarini J, Alib R. Int. J. Mol. Sci. 2022; 23: 9704
40 Mishra S, Modicom FC. T, Dean CL, Fletcher SP. Commun. Chem. 2022; 5: 154
41 Trost BM, Xu S, Sharif EU. J. Am. Chem. Soc. 2019; 141: 10199
42 Patel NR, Huffman MA, Wang X, Ding B, McLaughlin M, Newman JA, Andreani T, Maloney KM, Johnson HC, Whittaker AM. Chem. Eur. J. 2020; 26: 14118
43 Wang H.-X, Guan F.-J, Xie M.-S, Qu G.-R, Guo H.-M. Adv. Synth. Catal. 2018; 360: 2233
44 Peifer M, Berger R, Shurtleff VW, Conrad JC, Macmillan DW. C. J. Am. Chem. Soc. 2014; 136: 5900
45 Simonovich SP, Van Humbeck JF, MacMillan DW. C. Chem. Sci. 2012; 3: 58
46 Dalençon S, Youcef RA, Pipelier M, Maisonneuve V, Dubreuil D, Huet F, Legoupy S. J. Org. Chem. 2011; 76: 8059
47 Xie MS, Zhou P, Niu HY, Qu GR, Guo HM. Org. Lett. 2016; 18: 4344
48 Wang H.-X, Li W.-P, Zhang M.-M, Xie M.-S, Qu G.-R, Guo H.-M. Chem. Commun. 2020; 56: 11649
49 Li J.-P, Zhao GF, Wang H.-X, Xie M.-S, Qu G.-R, Guo H.-M. Org. Lett. 2017; 19: 6494
50 Huang KX, Xie MS, Zhao GF, Qu GR, Guo HM. Adv. Synth. Catal. 2016; 358: 3627
51 Li H, Zhu S, Zheng G. Bioorg. Med. Chem. Lett. 2018; 28: 1071
52 Su Y, Gao S, Li H, Zheng G. Process Biochem. 2018; 72: 96
53 Arita M, Adachi K, Ito Y, Sawai H, Ohno M. J. Am. Chem. Soc. 1983; 105: 4049
54 McLaughlin M, Kong J, Belyk KM, Chen B, Gibson AW, Keen SP, Lieberman DR, Milczek EM, Moore JC, Murray D, Peng F, Qi J, Reamer RA, Song ZJ, Tan L, Wang L, Williams MJ. Org. Lett. 2017; 19: 926
55 Ni G, Du Y, Tang F, Liu J, Zhao H, Chen Q. RSC Adv. 2019; 9: 14302
56 Wang Q, Mu J, Zeng J, Wan L, Zhong Y, Li Q, Li Y, Wang H, Chen F. Nat. Commun. 2023; 14: 138
57 Kang B, Zhang Q.-Y, Qu G.-R, Guo H.-M. Adv. Synth. Catal. 2020; 362: 1955
58 De Clercq E. Antiviral Res. 2007; 75: 1
59 De Clercq E, Holý A. Nat. Rev. Drug Discov. 2005; 4: 928
60 Pal S, Chandra G, Patel S, Singh S. Chem. Rec. 2022; 22: e202100335
61 Pack EJ. Jr, Bleiberg B, Rosenberg IE. Chirality 1990; 2: 275
62 Kiesewetter DO, Knudson K, Collins M, Srinivasula S, Lim E, Di Mascio M. J. Labelled Compd. Radiopharm. 2008; 51: 187
63 Brodfuehrer PR, Howell HG, Sapino CJr, Vemishetti P. Tetrahedron Lett. 1994; 35: 3243
64 Vemishetti P, Saibaba R, Panzica RP, Abushanab E. J. Med. Chem. 1990; 33: 681
65 Guo H.-M, Wu Y.-Y, Niu H.-Y, Wang D.-C, Qu G.-R. J. Org. Chem. 2010; 75: 3863
66 Azzouz M, Soriano S, Escudero-Casao M, Matheu MI, Castillón S, Díaz Y. Org. Biomol. Chem. 2017; 15: 7227
67 Guo H.-M, Wu S, Niu H.-Y, Song G, Qu G.-R. Chemical Synthesis of Acyclic Nucleosides . In Chemical Synthesis of Nucleoside Analogues . Merino P. John Wiley & Sons; Hoboken: 2013: 103
68 Wei T, Xie M.-S, Qu G.-R, Niu H.-Y, Guo H.-M. Org. Lett. 2014; 16: 900
69 Evans PA, Lai KW, Zhanga H.-R, Huffman JC. Chem. Commun. 2006; 844
70 Gandelman M, Jacobsen EN. Angew. Chem. Int. Ed. 2005; 44: 2393
71 Wu H, Tian Z, Zhang L, Huang Y, Wang Y. Adv. Synth. Catal. 2012; 354: 2977
72 Guo H.-M, Yuan T.-F, Niu H.-Y, Liu J.-Y, Mao R.-Z, Li D.-Y, Qu G.-R. Chem. Eur. J. 2011; 17: 4095
73 Trost BM, Madsen R, Guile SG, Elia AE. H. Angew. Chem., Int. Ed. Engl. 1996; 35: 1569
74 Trost BM, Madsen R, Guile SD, Brown B. J. Am. Chem. Soc. 2000; 122: 5947
75 Amblard F, Nolan SP, Gillaizeau I, Agrofoglio LA. Tetrahedron Lett. 2003; 44: 9177
76 Niu H.-Y, Du C, Xie M.-S, Wang Y, Zhang Q, Qu G.-R, Guo H.-M. Chem. Commun. 2015; 51: 3328
77 Stanley LM, Hartwig JF. J. Am. Chem. Soc. 2009; 131: 8971
78 Liang L, Xie M.-S, Qin T, Zhu M, Qu G.-R, Guo H.-M. Org. Lett. 2017; 19: 5212

79a Xia C, Wang DC, Qu GR, Guo HM. Org. Chem. Front. 2021; 8: 2569
79b Wang H, Yu L, Xie M, Wu J, Qu G, Ding K, Guo H. Chem. Eur. J. 2018; 24: 1425

80 Thieme N, Breit B. Angew. Chem. Int. Ed. 2017; 56: 1520
81 Liang L, Niu HY, Xie MS, Qu GR, Guo HM. Org. Chem. Front. 2018; 5: 3148
82 Sun HL, Chen F, Xie MS, Guo HM, Qu GR, He YM, Fan QH. Org. Lett. 2016; 18: 2260
83 Zhang Q, Ma BW, Wang QQ, Wang XX, Hu X, Xie MS, Qu GR, Guo HM. Org. Lett. 2014; 16: 2014
84 Qin T, Li JP, Xie MS, Qu GR, Guo HM. J. Org. Chem. 2018; 83: 15512